|
AU2005253776A1
|
|
Screening methods using c-Abl, Fyn and Syk in combination with tau protein
|
|
GB0426859D0
|
|
Diagnosis of neurodegenerative disorders
|
|
GB0421639D0
|
|
Methods and compositions relating to alzheimer's disease
|
|
GB0419124D0
|
|
Methods and compositions relating to Alzheimer's disease
|
|
AU2003274368A1
|
|
Diagnostic method for transmissible spongiform encephalopathies (prion diseases)
|
|
GB0314943D0
|
|
Screening methods
|
|
AU2002318434B2
|
|
Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids
|
|
US2002099086A1
|
|
Use of extracts from aristolochia in the treatment of AIDS
|
|
WO0116603A2
|
|
Analysis and treatment of body weight and eating disorders
|
|
CA2375850A1
|
|
Method and compositions relating to insulin resistance disorders
|
|
GB9912743D0
|
|
Method and kit for ligand assay
|
|
GB9912741D0
|
|
Method of screening for an agent for treating insulin-related disorders
|
|
EP1117415A1
|
|
Use of extracts from aristolochia in the treatment of aids
|
|
CA2298677A1
|
|
Pharmaceutical compounds isolated from aristolochia taliscana
|
|
WO9842736A1
|
|
Diagnosis of colorectal cancer and proteins and antibodies for use therein
|
|
AU5059798A
|
|
Diagnosis of prion diseases
|
